Skip to main content
Clinical Trials/CTRI/2021/08/036026
CTRI/2021/08/036026Completed未知

To evaluate the effectiveness of add on repetitive transcranial magnetic stimulation (rTMS) in management of post-stroke spasticity a randomized control trial.

Aiims Bhubaneswar0 sites50 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. First-time stroke
  • 2. Stroke at least three months prior to onset of study with chronic sequela of spasticity
  • 3. Stroke location- either cortical or subcortical
  • 4. Stroke type- either hemorrhagic or ischemic
  • 5. Stroke hemisphere- either left or right, dominant or non- dominant hemisphere
  • 6. 18 years of age or older
  • 7. Gender- either male or female
  • 8. Ability to follow three-step directions
  • 9. Demonstration of 10 degrees of active extension at the metacarpophalangeal joint and wrist of the paretic upper extremity
  • 10. Sufficient ambulation or wheelchair mobility to allow subject to present to treatment and testing areas with minimum assistance

Exclusion Criteria

  • 1. History of seizure within the past two years
  • 2. Inability to follow three-step directions
  • 3. Anosognosia
  • 4. Moderate to severe receptive aphasia
  • 5. Inability to give informed consent
  • 6. Premorbid spasticity or neurologic impairment prior to stroke
  • 7. Co-morbidities impairing upper extremity function such as fracture or deformity
  • 8. Indwelling metal or medical devices incompatible with TMS
  • 9. Pregnancy
  • 10. Bi-hemispheric or multifocal stroke
  • 11. Severe dementia
  • 12. Neurolytic injection within the 3 months prior to onset of study or planned neurolytic injection during study period

Investigators

Similar Trials